VeriSIM Life logo

VeriSIM Life

VeriSIM was founded in 2017 by Dr. Jo Varshney, a multidisciplinary and celebrated leader in veterinary & human health development. Together with a team of world-class scientists, machine learning engineers and in silicon simulation experts the team is bringing clarity to drug development through computational sciences rather than the existing trial and error experimentation approach. 
The leadership believes that with their machine learning-driven approach, they can  pre-flight advancements in medicine without the need for redundant trials, subjecting animals to the cruelty of testing, and with far better outcomes than the  8% success currently seen in medicine making it to market. More people will be able to receive the treatments they require and our partners will see faster and verified results from their research.

Content by VeriSIM Life

A hand reaching out to touch an artificial projection of another hand, mirrored
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

A 3D rendering illustrates a sandwich ELISA technique, where antigen detection is achieved between two layers of antibodies: a capture antibody and a detection antibody
Learn the key characteristics that determine whether an immunoassay generates accurate and reproducible data.
Digital illustration of a glowing DNA double helix surrounded by interconnected circuit-like lines on a dark blue background.
Learn the key differences between chemical and enzymatic approaches to synthetic DNA production and their implications for modern research.
Abstract illustration of a DNA double helix surrounded by geometric shapes, interconnected lines, and circular data-inspired design elements on a light background.
Discover how codon optimization influences gene expression, protein production, and synthetic DNA design across diverse expression systems.
Drug Discovery News December 2025 Issue
Latest IssueVolume 21 • Issue 4 • December 2025

December 2025

December 2025 Issue

Explore this issue